A Multicenter, Randomized, Open Label, Parallel Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf in Combination With Steroids in Patients Undergoing Liver Transplantation and a Pharmacokinetics Study.

Trial Profile

A Multicenter, Randomized, Open Label, Parallel Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf in Combination With Steroids in Patients Undergoing Liver Transplantation and a Pharmacokinetics Study.

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Feb 2016

At a glance

  • Drugs Corticosteroids; Tacrolimus
  • Indications Liver transplant rejection
  • Focus Therapeutic Use
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 10 Mar 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
    • 10 Mar 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Jul 2008 The expected completion date for this trial has been extended from May 2008 to Sep 2008 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top